UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

Journal of hematology and oncology, 2021-05, Vol.14 (1), p.81-81, Article 81

2021

Volltextzugriff (PDF)

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

The New England journal of medicine, 2021-05, Vol.384 (19), p.1810-1823

2021

Volltextzugriff (PDF)

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia

Journal of hematology and oncology, 2021-07, Vol.14 (1), p.1-119, Article 119

2021

Volltextzugriff (PDF)

Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience

Frontiers in oncology, 2022-12, Vol.12, p.897937-897937

2022

Volltextzugriff (PDF)

PB2416: EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM

HemaSphere, 2023-08, Vol.7 (S3), p.e1507485-n/a

2023

Volltextzugriff (PDF)

The 12‐week kinetics of anti‐SARS‐CoV‐2 antibodies in different haematological cancers after vaccination with BNT162b2

British journal of haematology, 2022-01, Vol.196 (2), p.362-367

2022

Volltextzugriff (PDF)

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

Haematologica (Roma), 2006-08, Vol.91 (8), p.1068-1075

2006

Volltextzugriff (PDF)

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Blood, 2018-11, Vol.132 (Supplement 1), p.5550-5550

2018

Volltextzugriff (PDF)

Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature review

American journal of hematology, 2002-01, Vol.69 (1), p.67-71

2002

Volltextzugriff (PDF)

LDH as Predictive Parameter in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S213-S213

2018

Volltextzugriff (PDF)

Fungal CNS infections in patients with hematologic malignancy

Expert review of anti-infective therapy, 2005-10, Vol.3 (5), p.775-785

2005

Volltextzugriff (PDF)

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

Annals of hematology, 2014-07, Vol.93 (7), p.1261-1262

2014

Volltextzugriff (PDF)

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome

Annals of hematology, 2011-01, Vol.90 (1), p.59-65

2011

Volltextzugriff (PDF)

All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients

American journal of therapeutics, 2007-07, Vol.14 (4), p.351

2007

Volltextzugriff (PDF)

AML-M4: Role of Eosinophilia and Cytogenetics on Treatment Response and Survival. The GIMEMA Experience

Blood, 2005-11, Vol.106 (11), p.4501-4501

2005

Volltextzugriff (PDF)

T/NK “Nasal Type” Lymphomas: An Italian Cooperative Retrospective Survey

Blood, 2004-11, Vol.104 (11), p.4578-4578

2004

Volltextzugriff (PDF)

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre

Leukemia & lymphoma, 2003-08, Vol.44 (8), p.1441-1443

2003

Volltextzugriff (PDF)

Letter to the Editor

Leukemia & lymphoma, 2003-01, Vol.44 (8), p.1441-1443

2003

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(19)
Humans
(15)
Hematology
(10)
Male
(10)
Oncology
(10)
Aged
(9)
Female
(8)
Italy
(8)
Middle Aged
(8)
Earthquakes
(7)
Aged, 80 And Over
(6)
Europe
(6)
Leukemia
(6)
Southern Europe
(6)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(5)
Biological And Medical Sciences
(5)
Seismology
(5)
Covid-19 Vaccines
(4)
Faults
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia

Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

PB2416: EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region

The 12‐week kinetics of anti‐SARS‐CoV‐2 antibodies in different haematological cancers after vaccination with BNT162b2

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim

The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature review

LDH as Predictive Parameter in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

Fungal CNS infections in patients with hematologic malignancy

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome

All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients

Epidemiology of Fungal Infections in Hematological Malignancies in Italy: SEIFEM-2004 Study (Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne)

AML-M4: Role of Eosinophilia and Cytogenetics on Treatment Response and Survival. The GIMEMA Experience

T/NK “Nasal Type” Lymphomas: An Italian Cooperative Retrospective Survey

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre

Letter to the Editor

Suchergebnisse filtern